Skip to content

Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction

Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02673268
Acronym
MARCI
Enrollment
80
Registered
2016-02-03
Start date
2015-11-25
Completion date
2020-11-30
Last updated
2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The objective of this study is to demonstrate the feasibility of a mastectomy with conservation of the areola using axillary way only with the Da Vinci Robot Xi and immediate breast reconstruction using prosthesis. The interest is to avoid scars on the breast. The scars are limited to the armpit and under the arm. The aim is also to study the rate of complications, cosmetic results and quality of life.

Interventions

PROCEDUREMastectomy
DEVICEDa Vinci Robot Xi

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1 .Patients with an indication of mastectomy with areola conservation 2. In case of carcinologic surgery: * Disease located more than 2cm of the areola on the clinical and paraclinical evaluation * Patients with indication of total mastectomy * Patients looking for immediate reconstruction 3. In case of prophylactic surgery * Patients wishing a prophylactic surgery because of highly risked mutation (BRCA1, BRCA2....) 4. Cup A, B or C maximum 5. Aged between 18 and 70 years old 6. OMS 0, 1 7. Signed informed consent 8. Patients affiliated to a social security system

Exclusion criteria

1. Patients with a high risk of skin necrosis 2. Planned post operative radiotherapy 3. Patients with an historic of breast surgery on the side that needs to be operated 4. Pregnant or breastfeeding women 5. Persons deprived of liberty 6. Persons not able to undergo medical follow up due to geographical, social or psychic reasons

Design outcomes

Primary

MeasureTime frame
Rate of necrosisAssessed up to 1 year

Countries

France

Contacts

Primary ContactBenjamin Sarfati, MD
Benjamin.sarfati@gustaveroussy.fr0142114384
Backup ContactStefan Michels, PhD
Stefan.michiels@gustaveroussy.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026